Ordopidine
CAS No. 871351-60-9
Ordopidine ( —— )
产品货号. M34675 CAS No. 871351-60-9
Ordopidine (ACR325) is a dopaminergic stabilizer that suppresses psychostimulant-induced hyperactivity disorder and stimulates behavior during inactivity. Ordopidine acts as a dopamine D2 receptor antagonist in vitro and, despite its low affinity, its specific state-dependent behavioral effect characteristics are not generally shared by D2 receptor antagonists.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥969 | 有现货 |
|
| 10MG | ¥1454 | 有现货 |
|
| 25MG | ¥2306 | 有现货 |
|
| 50MG | ¥3339 | 有现货 |
|
| 100MG | ¥4572 | 有现货 |
|
| 200MG | ¥6147 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Ordopidine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Ordopidine (ACR325) is a dopaminergic stabilizer that suppresses psychostimulant-induced hyperactivity disorder and stimulates behavior during inactivity. Ordopidine acts as a dopamine D2 receptor antagonist in vitro and, despite its low affinity, its specific state-dependent behavioral effect characteristics are not generally shared by D2 receptor antagonists.
-
产品描述Ordopidine (ACR325) is a dopaminergic stabilizer that suppresses psychostimulant-induced hyperactivity disorder and stimulates behavior during inactivity. Ordopidine acts as a dopamine D2 receptor antagonist in vitro and, despite its low affinity, its specific state-dependent behavioral effect characteristics are not generally shared by D2 receptor antagonists.
-
体外实验——
-
体内实验——
-
同义词——
-
通路GPCR/G Protein
-
靶点Dopamine Receptor
-
受体Dopamine Receptor
-
研究领域——
-
适应症——
化学信息
-
CAS Number871351-60-9
-
分子量285.38
-
分子式C14H20FNO2S
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESFC1=C(C=CC=C1S(C)(=O)=O)C2CCN(CC)CC2
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
产品手册
关联产品
-
Alizapride hydrochlo...
盐酸阿利扎必利是一种多巴胺受体拮抗剂,用于治疗恶心和呕吐。
-
N,N-Dimethylglycine
N,N-二甲基甘氨酸用作运动表现增强剂和免疫刺激剂。它还用于治疗自闭症、癫痫和线粒体疾病。
-
MPTP-Hydrochloride
MPTP(盐酸盐)是神经毒素 MPP 的前药,可引起帕金森病的永久性症状。
021-51111890
购物车()
sales@molnova.cn

